Search
for
Sort by
Research 361–390 of 1000+
- Testosterone, cytochrome P450, and cardiac hypertrophy
- Testosterone modulation of seizure susceptibility is mediated by neurosteroids 3α-androstanediol and 17β-estradiol
- Effect of Testosterone Supplementation With and Without a Dual 5α-Reductase Inhibitor on Fat-Free Mass in Men With Suppressed Testosterone Production
- Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis
- Effect of caffeine and testosterone on the proliferation of human hair follicles <i>in vitro</i>
- Short‐ and Long‐Term Clinical Skin Effects of Testosterone Treatment in Trans Men
- Effects of Intramuscular Testosterone Undecanoate on Body Composition and Bone Mineral Density in Female-to-Male Transsexuals
- Testosterone, Dihydrotestosterone, and Incident Cardiovascular Disease and Mortality in the Cardiovascular Health Study
- Testosterone and doping control
- Puberty in Boys: Correlation of Plasma Levels of Gonadotropins (LH, FSH), Androgens (Testosterone, Androstenedione, Dehydroepiandrosterone and Its Sulfate), Estrogens (Estrone and Estradiol) and Progestins (Progesterone and 17-Hydroxyprogesterone)
- Testosterone Supplementation for Aging-Associated Sarcopenia
- Free Testosterone: Pumping up the Tires or Ending the Free Ride?
- Exogenous Testosterone Alone or With Finasteride Does Not Improve Measurements of Cognition in Healthy Older Men With Low Serum Testosterone
- Testosterone Metabolism in the Skin
- Potential adverse effects of long-term testosterone therapy
- Physical Changes, Laboratory Parameters, and Bone Mineral Density During Testosterone Treatment in Adolescents with Gender Dysphoria
- Obstructive Sleep Apnea Due to Endogenous Testosterone Production in a Woman
- The use of a transscrotal testosterone delivery system in the treatment of patients with weight loss related to human immunodeficiency virus infection
- The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness.
- Cellular actions of testosterone in vascular cells: Mechanism independent of aromatization to estradiol
- Testosterone alters iron metabolism and stimulates red blood cell production independently of dihydrotestosterone
- Central 5-alpha reduction of testosterone is required for testosterone's inhibition of the hypothalamo-pituitary–adrenal axis response to restraint stress in adult male rats
- Androgen-Dependent Beard Dermal Papilla Cells Secrete Autocrine Growth Factor(s) in Response to Testosterone Unlike Scalp Cells
- Genetic predictors of testosterone and their associations with cardiovascular disease and risk factors: A Mendelian randomization investigation
- Measurement of Cortisol and Testosterone in Hair of Obese and Non-Obese Human Subjects
- Safety of testosterone use in women
- Differential Suppression of Testosterone and Estradiol in Hirsute Women With the Superactive Gonadotropin-Releasing Hormone Agonist Leuprolide*
- Biochemical Roles of Testosterone and Epitestosterone to 5α-Reductase as Indicators of Male-Pattern Baldness
- Overexpression of aldo-keto reductase 1C3 (AKR1C3) in LNCaP cells diverts androgen metabolism towards testosterone resulting in resistance to the 5α-reductase inhibitor finasteride
- Aromatase-independent testosterone conversion into estrogenic steroids is inhibited by a 5α-reductase inhibitor